Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002

被引:74
作者
Toracchio, S [1 ]
Marzio, L [1 ]
机构
[1] Univ G dAnnunzio, Dept Med & Aging, Internal Med Unit, Presidio Osped Spirito Santo, I-65124 Pescara, Italy
关键词
antibiotic resistance; Helicobacter pylori; susceptibility testing;
D O I
10.1016/S1590-8658(03)00265-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Antibiotic resistance of Helicobacter pylori is the most common reason for failure in its eradication. Aim. To determine the incidence of primary and secondary resistance to tinidazole, clarithromycin and amoxycillin in Helicobacter pylori isolates from dyspeptic patients in central Italy and to evaluate the modifications of resistance over the period from 1998 to 2002. Methods. H. pylori strains were isolated from antral biopsies taken during upper endoscopy in 406 dyspeptic patients with no previous therapy against H. pylori, and in 96 patients who had already undergone one or more triple therapies. Antibiotic susceptibility test was performed using the screening agar method and agar dilution method. Results. Overall primary resistance to tinidazole, clarithromycin and amoxycillin was 36.7, 23.4 and 0.2%, respectively. Secondary resistance rates were: tinidazole 69.8%, clarithromycin 82.3% and amoxycillin 1%. Resistance to clarithromycin was often associated with tinidazole resistance and was significantly higher in female patients (p<0.05). Primary and secondary antibiotic resistance did not change during the 4 years of observation. Conclusions. The dyspeptic population with H. pylori infection in central Italy shows high levels of antibiotic resistance. Primary resistance to clarithromycin is most frequent in female patients. In patients with secondary resistance, dual resistance to clarithromycin and tinidazole is found in the majority of cases. (C) 2003 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:541 / 545
页数:5
相关论文
共 27 条
[1]  
Bazzoli F, 2000, DIGEST LIVER DIS, V32, pS207
[2]   Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years [J].
Boyanova, L ;
Spassova, Z ;
Krastev, Z ;
Petrov, S ;
Stancheva, I ;
Docheva, J ;
Mitov, I ;
Koumanova, R .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (04) :309-313
[3]   Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) [J].
Cabrita, J ;
Oleastro, M ;
Matos, R ;
Manhente, A ;
Cabral, J ;
Barros, R ;
Lopes, AI ;
Ramalho, P ;
Neves, BC ;
Guerreiro, AS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1029-1031
[4]   Variation in antibiotic use in the European Union [J].
Cars, O ;
Mölstad, S ;
Melander, A .
LANCET, 2001, 357 (9271) :1851-1853
[5]   Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands [J].
Debets-Ossenkopp, YJ ;
Herscheid, AJ ;
Pot, RGJ ;
Kuipers, EJ ;
Kusters, JG ;
Vandenbroucke-Grauls, CMJE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :511-515
[6]   There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia [J].
Des Varannes, SB ;
Fléjou, JF ;
Colin, R ;
Zaïm, M ;
Meunier, A ;
Bidaut-Mazel, C .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (08) :1177-1185
[7]  
Dore MP, 1997, GASTROENTEROLOGY, V112, pA105
[8]   Helicobacter pylori [J].
Dunn, BE ;
Cohen, H ;
Blaser, MJ .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :720-+
[9]  
Fedorak R, 1997, GASTROENTEROLOGY, V112, pA115
[10]   Antibiotic resistance in Helicobacter pylori:: Implications for therapy [J].
Graham, DY .
GASTROENTEROLOGY, 1998, 115 (05) :1272-1277